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Abstract 
Objective Responsiveness to direct verbal suggestions (suggestibility) has long been hypothesized to 
represent a predisposing factor for functional neurological disorder (FND) but previous research has yielded 
conflicting results. The aim of this study was to quantitatively evaluate whether FND patients display 
elevated suggestibility relative to controls via meta-analysis.  
Methods Four electronic databases were searched in November 2019, with the search updated in April 
2020, for original studies assessing suggestibility using standardized behavioural scales or suggestive 
symptom induction protocols in FND (including somatization disorder) patients and controls. The meta-
analysis followed Cochrane, PRISMA, and MOOSE guidelines. Data extraction and study quality coding 
were performed by two independent reviewers. Standardized suggestibility scores and responsiveness to 
symptom induction protocols were used to calculate standardized mean differences (SMDs) between groups. 
Results Of 26,643 search results, 19 articles presenting 11 standardized suggestibility datasets (FND: 
n=316; control: n=360) and 11 symptom suggestibility datasets (FND: n=1285; control: n=1409) were 
included in random-effects meta-analyses. Meta-analyses revealed that FND patients displayed greater 
suggestibility than controls on standardized behavioural scales (SMD, 0.48 [95% CI, 0.15, 0.81]) and greater 
responsiveness to suggestive symptom induction (SMD, 1.39 [95% CI, 0.92, 1.86]). Moderation analyses 
presented mixed evidence regarding the extent to which effect sizes covaried with methodological 
differences across studies. No evidence of publication bias was found. 
Conclusions These results corroborate the hypothesis that FND is characterized by heightened 
responsiveness to verbal suggestion. Atypical suggestibility may confer risk for FND and be a cognitive 
marker that can inform diagnosis and treatment of this condition.  
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Introduction 
Functional neurological disorder (FND) is characterized by impaired motor, cognitive and/or sensory 
functioning that resembles neurological pathology but is not adequately explained by, and is clinically 
distinguishable from, it.1, 2 FND encompasses a diverse array of symptom subtypes including non-epileptic 
seizures, functional movement disorder, and somatization disorder, and is often conceptualized as a 
dissociative disorder.3 Previously referred to as hysteria, and also known as conversion disorder, functional 
neurological symptom disorder, and dissociative neurological symptom disorder, FND has a prevalence of 
4-12 per 100,0004, 5 and is found in ~16% of neurology outpatients.6 It is associated with considerable 
diagnostic delays and frequent misdiagnosis,7 which add to the already significant psychological, social, and 
economic impact of the condition.8 
FND has long been hypothesized to be characterized by elevated responsiveness to direct verbal 
suggestions (suggestibility)9 and suggestion and the expression of functional symptoms have been 
hypothesized to recruit overlapping mechanisms.10 Suggestibility is theorized to confer vulnerability for 
FND11 through aberrant meta-awareness of intentions,12-15 the capacity for suggestions to trigger 
automatized behavioural routines or mental representations,11 and/or a tendency to form precise (symptom) 
priors that override motor and perceptual systems.16, 17 The use of suggestion to provoke FND symptoms is 
widely used to aid diagnosis18, 19 and functional symptoms are responsive to suggestion-based treatments, 
such as hypnosis and placebo.20 Conditions with germane symptom profiles, such as dissociative disorders, 
are also characterized by elevated hypnotic suggestibility.21  
Despite these various strands of evidence, the empirical association between suggestibility and FND 
seems to be highly variable.10, 22 In order to quantify the evidence for atypical suggestibility in this 
population, we conducted a random-effects meta-analysis of controlled studies of suggestibility on 
standardized behavioural scales and in response to suggestive symptom induction protocols in all FND 
subtypes including somatization disorder/Briquet’s syndrome. Secondary analyses investigated moderating 
influences on patient-control differences, including FND subtype, experimenter blindness,23 methodological 
quality, the inclusion of a hypnotic induction,24 and symptom provocation method.18  
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Method 
Eligibility criteria 
Inclusion criteria included (1) English language; (2) full paper in a peer-reviewed journal; (3) patient sample 
characterized by FND/symptoms, encompassing conversion disorder (DSM), dissociative neurological 
disorder (ICD), specific functional neurological syndromes (e.g., non-epileptic seizures), and conditions 
where functional neurological symptoms are a diagnostic feature (i.e. DSM-IV somatization disorder; 
Briquet’s syndrome); (4) inclusion of a control group; and either (5) use of a standardized behavioural 
measure of direct verbal suggestibility24, or (6) assessment of symptom induction through suggestion (e.g., 
suggestive seizure induction18).  
Exclusion criteria included (1) studies in which suggestion was used to aid diagnosis; (2) case 
studies/series or non-empirical papers; (3) overlapping/insufficient data; (4) use of interrogative 
suggestibility scales, which capture a different form of suggestibility characterized by high compliance25; 
and (5) studies of patients with functional somatic syndromes not specifically characterized by functional 
neurological symptoms (e.g., fibromyalgia). 
 
Search strategy 
PubMed, PsycINFO, Web of Science and Academic Search Complete databases were searched in November 
2019 for eligible studies using terms relating to suggestibility and FND (see online supplemental content 
1) and then integrated into a single database. The search was repeated in April 2020 but yielded no new 
studies. The reference lists of all eligible studies (and relevant review papers) were manually searched to 
identify additional studies. Authors were contacted when data were unavailable or to clarify ambiguities in 
methodology.  
 
Study selection 
Two raters (LW and a second rater) independently screened and assessed all studies for their eligibility using 
a two-stage procedure. First, all titles and abstracts were screened and articles not meeting eligibility criteria 
were rejected. Second, all remaining papers were reviewed to establish a final list of articles. Discrepancies 
at either stage were resolved in consultation with a third reviewer (DBT) and sometimes a fourth reviewer 
(RJB). Authors of eligible studies were contacted to address any questions regarding insufficient data. Of 5 
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author groups contacted, 4 (80%) provided data sufficient to permit study inclusion or answered queries that 
justified exclusion. 
 
Data extraction 
The two outcome types (standardized suggestibility and symptom suggestibility) were measured using 
continuous and categorical measures, respectively. After exclusion of two studies with overlapping data, 
data from eligible studies were extracted and coded independently by LW and the second rater using a data 
extraction form including: (i) study details (title, year, geographical location), (ii) diagnosis, (iii), diagnosis 
method, (iv) demographics (sample size and gender and age distributions), (v) study design details 
(suggestibility type [standardized or symptom], inclusion of a hypnotic induction, scale, administration 
method [live or recorded presentation], and scoring method [self or experimenter]), provocation method [see 
Table 2], symptom subtype, experimenter blindness [blind, unblind, or unreported]), and (vi) descriptive 
statistics (Ms and SDs [standardized suggestibility] or response counts [symptom suggestibility]). Symptom 
suggestibility response counts include only responses identified as typical for the respective patient 
(typicality reported: k=8; unreported: k=3). When studies reported results for more than one provocation 
method (k=2), the rounded mean was used. Two studies included data for both standardized and symptom 
suggestibility. There was 91% agreement between the two raters and discrepancies were resolved with a 
third reviewer (DBT). 
 
Study quality 
A 13-item scale was developed to assess study quality (see online supplemental content 1). Items were 
adapted from an earlier meta-analysis that included items based on Cochrane criteria and PRISMA 
recommendations26 and a range of other methodological criteria such as experimenter blindness. LW and the 
second rater independently rated each item categorically (0=criterion not met, 1=criterion met) and a 
summed total was computed for each study. Agreement between raters was 90% (kappa=.73) and 
discrepancies were resolved with DBT.  
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Meta-analysis and meta-regression 
Individual study effect sizes included between-group differences in suggestibility that were computed with 
standardised mean differences (SMDs; Hedges’s gs) using Review Manager (RevMan v. 5.3, 2014; The 
Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen). Symptom suggestibility data consisted 
of binary outcomes that were used to compute odds ratios, which were subsequently transformed to SMDs27 
in MATLAB (v. 2017b, MathWorks, Natick, MA). SMDs were coded such that positive values reflected 
greater suggestibility in FND patients than controls. SMDs around 0.2, 0.5, and 0.8 are typically interpreted 
as reflecting small, moderate, and large effects, respectively. 
Publication bias was assessed by examining funnel plots of effect sizes against standard errors for 
asymmetry, as might occur due to a small number of studies with small or non-significant effect sizes. We 
also tested for asymmetry using Egger’s bias test28 where p<.05 is indicative of asymmetry and we report 
revised effect sizes correcting for asymmetry using the trim-and-fill method29 and funnel plots. 
Random-effects meta-analyses were performed in JASP (v. 0.8.6, 2019; JASP Team, Netherlands). 
Outlier detection was made on the basis of studentized residuals (>|3.3|).30 There were no outliers in the 
standardized suggestibility data (range: -1.63 to 1.33) or the symptom suggestibility data (range: -2.01 to 
1.26). Moderating effects were assessed using meta-regression analyses whenever data were available for at 
least 2 studies at each level of a categorical moderator and at least 10 studies for continuous moderators.31 
Moderators included five categorical measures (symptom subtype, experimenter blindness, hypnotic 
induction, symptom provocation method [suggestion vs. nocebo; symptom studies], symptom typicality [not 
reported vs. report; symptom studies]; and control type [non-clinical vs. clinical; standardized studies]) and 
one continuous measure (methodological quality). 
 
Results 
Study inclusion 
A PRISMA diagram showing study selection is presented in Figure 1. Principal features of these studies, 
including diagnosis criteria and procedures, are presented in Tables 1 and 2. 
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Figure 1. PRISMA flowchart of study selection process. 
 
Table 1. Characteristics of included studies measuring standardized suggestibility in FND 
Source Diagnostic criteria FND Controls Scale Hypnotic 
induction 
Formal Procedure Diagnosis n  
(% 
female) 
Age  
[M (SD)] 
Diagnosis n  
(% 
female) 
Age  
[M (SD)] 
Khan et al., 2009 - MI NES 24 (-) - (-) ES 16 (-) - (-) HIP Y 
Brown et al., 2008 DSM-
IV 
CR SD 19 (95) 40.9 (14.1) DYS 17 (59) 45.4 (11.1) BSS N 
Roelofs et al., 2002 DSM-
IV 
MI mCD 50 (84) 37.2 (11.9) mAD 50 (82) 36.4 (11.1) SHSS:C Y 
Litwin and Cardeña, 
2001 
- MI NES 10 (100) 30.5 (9.9) ES 31 (45) 35.2 (8.9) SHCS Y 
Moene et al., 2001 / 
Spinhoven et al. 
1991* 
DSM-
III-R 
CR mCD 96 (-) - (-) NCC 82 (57) 40.1 (14.3) SHCS Y 
Barry et al., 2000 - MI, CR NES/ES 36 (-) - (-) ES 22 (-) - (-) HIP Y 
Goldstein et al., 
2000 
- MI, CR NES 20 (80) 34.4 (12.4) NCC 20 (45) 36 (8.5) CIS N 
Kuyk et al., 1999 - MI NES 20 (80) 25 (-) ES 17 (18) 37 (-) SHCS Y 
Kuyk et al., 1995 - MI, CR NES 6 (50) 19.3 ES 7 (14) 28.6 (-) SHCS Y 
Bliss, 1984a - CR mCD 18 (100) - (-) NCC 49 (-) - (-) SHSS:C  Y 
Bliss, 1984b - CR BS 17 (100) - (-) NCC 49 (-) - (-) SHSS:C Y 
Notes. BSS = Barber Suggestibility Scale; BS=Briquet’s syndrome; CIS = Creative Imagination Scale; CR=case note review for 
ruling out organic causes; DSM=Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association); 
DYS=dystonia; ES=epileptic seizures; FND=functional neurological disorder; HIP = Hypnotic Induction Profile; mAD=mixed 
affective disorders; mixed conversion disorder (mCD); MI=Medical investigations; NCC=non-clinical controls; NES=non-epileptic 
seizures; PDF=positive diagnostic features; SD=somatization disorder; SHCS = Stanford Hypnotic Clinical Scale; SHSS:C = 
Stanford Hypnotic Susceptibility Scale: Form C; - = Not reported; * = Control data were drawn from Spinhoven et al. (1991). 
 
 
Records identified through 
database searching 
(n = 26,642) 
Additional records identified 
through other sources 
(n = 1) 
Records after duplicate removal 
(n = 20,194) 
Records screened 
(n = 20,194) 
Records excluded (n = 19,575) 
Abstracts and/or full-text 
articles assessed for 
eligibility (n = 619) 
(n =   ) 
Full-text articles excluded (n = 600) 
Case studies: 212 
Non-clinical sample: 171 
Non-eligible clinical sample: 74 
No control group: 126 
Insufficient data: 5 
Duplicate data: 2 
Suggestion used for diagnosis: 10 
 
Studies included in 
quantitative synthesis 
(meta-analysis) (n = 22, 
from 19 papers) 
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Table 2. Characteristics of included studies measuring symptom suggestibility in FND 
Source Diagnostic criteria FND Controls  Method Responsiveness: n (%) 
Formal Procedure Diagnosis n (% 
female) 
Age  
[M (SD)] 
Diagnosis n (% 
female) 
Age  
[M (SD)] 
Suggestion/noceb
o 
Hypnotic 
induction 
FND Control 
Kandler et al., 
2018 
- MI, CR NES 416 (-) - (-) ES 568 (-) - (-) VS, HV, PS N 120 
(29%) 
40 (7%) 
Chen-Block et al., 
2016 
- MI, CR NES/ES 466 
(70) 
- (-) ES 581 
(54) 
- (-) VS, HV, PS, AP, 
ST 
 
N 240 
(52%) 
15 (3%) 
Goyal et al., 2014 - MI NES 140 
(71) 
21.38 
(10.83) 
ES 50 (34) 21.18 
(9.98) 
VS, PS, VTF, 
TC, MS, SI 
 
N 84 (60%) 0 (0%) 
Arain et al., 2009 - MI NES 24 (67) - (-) ES 54 (65) - (-) VS, HV  N 8 (33%) 6 (11%) 
Khan et al., 2009 - MI NES 24 (-) - (-) ES 16 (-) - (-) VS Y 11 (46%) 2 (13%) 
Kenney et al., 
2007 
FW PDF PT 12 (-) 42.5 (11) ET 33 (-) 56.8 (17) VS, HV, VTF N 6 (50%) 5 (15%) 
Martinez-Taboas, 
2002 
- CR, PDF  NES 8 (88) 32 (9.2) ES 5 (100) 30 (6.2) VS, ARS Y 8 (100%) 0 (0%) 
Barry et al., 2000 - MI, CR NES/ES 47 (-) - (-) ES 22 (-) - (-) VS Y 36 (77%) 1 (5%) 
Chabrol et al, 
1995 
DSM-
IV 
CR, PDF mCD 15 (-) 44 (14) mND 40 (-) 53 (17) VS N 6 (40%) 17 (43%) 
Lancman et al., 
1994 
- MI NES 93 (77) 26.7 (-) ES 20 (70) 28.2 (-) VS, AP N 72 (77%) 0 (0%) 
Walczak et al., 
1994 
 MI NES 40 (90) 33.9 (11.6) ES 20 (45) 34 (11.7) VS, SI N 33 (83%) 5 (25%) 
Notes. AP=alcohol patch; ARS=age regression suggestion; CR=case note review for ruling out organic causes; DSM=Diagnostic 
and Statistical Manual of Mental Disorders (American Psychiatric Association); ES=epileptic seizures; ET=essential tremor; 
FW=Fahn and Williams diagnostic criteria; HV=hyperventilation; MI=Medical investigations; mCD=mixed conversion disorder 
(mCD); mND=mixed neurological disorders; MS=moist swab; NES=non-epileptic seizures; PDF=positive diagnostic features; 
PS=photic stimulation; PT=psychogenic tremor; SI=saline injection; ST=subjective trigger; TC=temple compression; VS = verbal 
suggestion; VTF=vibrating tuning fork; - = Not reported. 
 
Study and participant characteristics 
The 19 papers included 11 standardized suggestibility studies (FND: n=316, control: n=360) and 11 
symptom suggestibility studies (FND: n=1285, control: n=1409) (see online supplemental content 1 for 
references). FND patients primarily comprised those with non-epileptic seizures (k=6 [standardized]; k=9 
[symptom]), with small numbers of studies of patients with mixed conversion disorder (k=3 [standardized] 
and k=1 [symptom]), somatization disorder/Briquet’s syndrome (k=2 [standardized]), and psychogenic 
tremor (k=1 [symptom]). The standardized studies were published between 1984 and 2009 and were 
conducted in the US (k=5), the Netherlands (k=4), and the UK (k=2). The symptom studies were published 
between 1994 and 2018, and were conducted in the US (k=7), Puerto Rico (k=1), France (k=1), India (k=1) 
and the UK (k=1). The mean percentage of females for standardized studies was 86.13 for FND (k=8) and 
45.71 for controls (k=7), whereas for symptom studies (k=6) it was 77.17 for FND and 61.33 for controls. In 
the standardized studies, the mean age for FND was 31.22 (SD=8.01) (k=6), and for controls it was 36.96 
(SD=5.09) (k=7), whereas for the symptom studies (k=6), mean age for FND was 33.41 (SD=8.79), and 
37.20 (SD=14.38) for controls.  
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Details of the types of standardized scales and provocation methods as well as the use of a hypnotic 
induction are provided in Table 1 and Table 2, respectively. A hypnotic induction was used in 9 
standardized studies and 3 symptom studies. All symptom studies included verbal suggestion but varied in 
their use of various nocebo procedures.  
 
Methodological quality criteria 
Ratings for each study on each of the methodological quality criteria items are shown in Supplementary 
Tables 1 and 2. Although some of the criteria were met by the majority of studies, multiple criteria were not 
reliably met. Only 5 of 22 studies (23%) reported that the experimenter was blind to group, 18 (82%) 
described the inclusion/exclusion criteria, 16 (73%) described the diagnosis procedure and criteria in 
adequate detail, 10 (45%) described participant characteristics and 3 (14%) exhibited demographic 
comparability between patients and controls. In the standardized studies, 7 of 11 (64%) described the scale 
and procedure in adequate detail, and only 1 (9%) included a measure to correct for compliance. In the 
symptom studies, 8 of 11 (73%) clearly described the provocation method.  
 
Meta-analysis of standardized suggestibility 
Meta-analysis of 11 standardized behavioural suggestibility studies found that patients with an FND 
exhibited greater suggestibility than controls, SMD=0.48 [0.15, 0.81], Z=2.84, p=.004 (see Figure 2). 
Positive results were observed in 8 studies with a high inconsistency of effect sizes across studies, I2=73%. 
Jackknife analysis in which each study effect was sequentially omitted and the analysis re-performed 
indicated that the group difference was reliably significant (SMD range: 0.40-0.56). 
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Figure 2. Forest plots of Standardised Mean Differences (SMDs) (with 95% confidence intervals) from 
(left) 11 standardized suggestibility studies and (right) 11 symptom suggestibility studies. Marker sizes 
reflect study weights with smaller markers denoting smaller weights. 
 
Meta-analysis of symptom suggestibility 
Meta-analysis of 11 symptom suggestibility studies found that patients with FND displayed greater 
responsiveness than controls, SMD=1.39 [0.92, 1.86], z=5.77, p<.001 (see Figure 2). Overall positive 
responses were observed in 49% of patients with FND and 6% of controls (sensitivity=49%, 
specificity=94%). Ten of the 11 studies exhibited positive SMDs although there was substantial 
heterogeneity in effect sizes across studies, I2=99%. Jackknife analysis revealed that the group difference 
remained significant after omitting each study in a sequential manner (SMD range: 1.25 to 1.54). 
 
Meta-analysis of standardized vs. symptom suggestibility  
The weighted effect size for symptom studies was significantly greater than that for standardized studies, 
z=2.60, p=.009. This difference remained stable, z=2.29, p=.022, after removing the two studies included in 
both data sets. When the two data sets were aggregated, the cumulative standardised effect size was slightly 
less than 1, SMD=0.96 [0.62, 1.29]. 
 
 
 
Summary SMD
Favours FNDFavours controls Favours FNDFavours controls
Source SMD [95% CI] SMD [95% CI]
Litwin & Cardeña 2001
Brown et al. 2008
Goldstein et al. 2000
Moene et al. 2001
Barry et al. 2000
Roelofs et al. 2002
Khan et al. 2009
Kuyk et al. 1999
Bliss 1984b
Bliss 1984a
Kuyk et al. 1995
Summary SMD
Source
Chabrol et al. 1995
Arain et al. 2009
Kandler et al. 2018
Kenney et al. 2007
Khan et al. 2009
Walczak et al. 1994
Martinez-Taboas 2002
Chen-Block et al. 2016
Barry et al. 2000
Lancman et al. 1994
Goyal et al. 2014
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Publication bias 
Egger’s test did not suggest asymmetry in the distribution of effect sizes in the standardized studies, z=0.69, 
p=.49, or in the symptom studies, z=1.50, p=.13. A trim-and-fill estimate produced only a slight reduction in 
effect sizes for standardized studies, ΔSMD=-.05, and symptom studies, ΔSMD=-.10 (see Figure 3). 
 
 
Figure 3. Funnel plots of standardized mean differences (SMDs) from (left) 11 standardised suggestibility 
studies and (right) 11 symptom suggestibility studies. Filled circles denote individual study effect sizes and 
empty circles denote estimated missing individual effect sizes due to publication bias imputed using the 
trim-and-fill method. Summary SMDs [95% CI] using the trim-and-fill method were SMD=0.43 [0.10, 0.76] 
(standardized suggestibility studies) and SMD=1.29 [0.84, 1.75] (symptom suggestibility studies). 
 
Meta-regression of standardized and symptom suggestibility 
Given the observed inconsistency in the magnitude of effects, a set of meta-regression analyses considered 
whether group differences were moderated by binary and continuous predictors pertaining to symptom 
subgroups and study methodologies (see Table 3). Non-epileptic seizure (NES) patients exhibited 
marginally significantly larger effect sizes than mixed-FND patients in the symptom studies although this 
difference was driven by a single non-significant mixed-FND study. These symptom subgroups did not 
significantly differ in the standardized studies. Effect sizes were significantly larger when a hypnotic 
induction was included in standardized studies, but not in symptom studies. Effect sizes were also larger in 
studies that reported whether suggested symptoms were typical for the patient relative to those that did not 
SMD
(standardized suggestibility) 
SMD
(symptom suggestibility) 
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report this information; this implies that effect sizes are not inflated by the inclusion of atypical symptoms in 
response rates for suggestive symptom induction. By contrast, effect sizes were not significantly related to 
the type of control (clinical vs. non-clinical; standardized studies) or suggestive induction protocol 
(suggestion vs. nocebo [suggestion and sham]; symptom studies). Experimenter blindness did not 
significantly moderate group differences with numerical differences in opposing directions for standardized 
and symptom studies. Similarly, methodological quality related to effect sizes in opposing directions: greater 
quality was significantly associated with lower effect sizes in standardized studies, but with larger, albeit 
non-significantly, effect sizes in symptom studies. These effects were primarily driven by procedure 
description. Standardized effect sizes were smaller in studies that met criteria for clarity of 
inclusion/exclusion criteria: z=-2.54, p=.011; diagnostic procedure: z=-2.82, p=.005; and scale 
administration procedure: z=-2.28, p=.022 (all other ps>.09). In contrast, symptom effect sizes were larger in 
studies that met criteria for clarity of diagnostic procedure, z=3.23, p=.001 (all other ps>.09).  
 
 
Table 3. Meta-regression analyses for standardized and symptom suggestibility studies (SMD [95% CIs] (k)) 
Moderator 
Suggestibility type 
 
 
Analysis groups 
 
Z 
 
p 
 
I2 
Symptom subgroup Mixed-FND NES    
Standardized 0.58 [0.10, 1.06] (5) 0.39 [-0.12, 0.90 (6) -0.54 .59 75% 
Symptom 0.43 [-0.54, 1.40] (2) 1.62 [1.09, 2.14] (9) 1.96 .050 99% 
Hypnotic induction No Yes    
Standardized -0.37 [-0.82, 0.09] (2) 0.66 [0.34, 0.97] (9) 2.74 .006 61% 
Symptom 1.30 [0.76, 1.85] (8) 1.66 [0.67, 2.64]) (3) 0.62 .54 100% 
Experimenter blindness Unblind Blind    
Standardized 0.46 [0.03, 0.89] (7) 0.54 [-0.09, 1.16] (4) 0.20 .84 76% 
Symptom 1.44 [0.94, 1.93] (10) 0.93 [0.61, 1.26] (1)    
Suggestive symptom 
induction method 
Suggestion Nocebo    
Symptom 1.20 [0.11, 2.28] (4) 1.50 [0.93, 2.08] (7) 0.69 .49 100% 
Suggestive symptom 
typicality 
Not reported Typical    
Symptom 0.60 [-0.14, 1.34] (3) 1.70 [1.14, 2.26] (8) 2.07 .038 100% 
Control sample type Non-clinical Clinical    
Standardized 0.58 [-0.08, 1.24] (4) 0.42 [0.01, 0.82] (7) -0.40 .69 76% 
Methodological quality     
Standardized 12-item scale -2.21 .027 66% 
Symptom 10-item scale 1.76 .079 99% 
Notes. FND=functional neurological disorder; NES=non-epileptic seizures 
 
 
 
 
 
Suggestibility in functional neurological disorder 13 
Discussion 
The results of this meta-analysis suggest that FND patients display elevated suggestibility on standardized 
behavioural scales and in response to suggestive symptom induction protocols, consistent with theoretical 
predictions to this effect.9, 10, 22 There was no evidence for publication bias although there was considerable 
heterogeneity in both data sets, which was partly explained by methodological variability.  
These findings are consistent with models proposing responsiveness to suggestion as a vulnerability 
factor for FND and those attributing functional symptoms to precise symptom priors.11, 16 Recent theoretical 
work conceptualizes functional symptoms as arising from the automatic activation of “rogue” mental 
representations or symptom priors akin to Janet’s fixed ideas. Numerous factors have been proposed to 
moderate this process including autonomic arousal, inhibitory deficits, and problems with body perception.11 
Suggestibility may confer heightened sensitivity to symptom-specific cues or dissociative responses to 
stressors.32 Moreover, suggestibility has been proposed to reflect a generalized tendency to form precise 
priors that override motor and perceptual systems,33 which is thought to be a key process in FND16 and 
symptom reporting more generally.17 This aligns with research showing that hypnotic suggestibility predicts 
symptom severity in FND patients.34 Observed links between hypnotic suggestibility and emotional 
responsiveness to social cues,24 highlight the potential role of suggestibility in symptom modelling or 
triggering through social observation.11 The perception that functional symptoms are extra-volitional may be 
further augmented by aberrant meta-awareness of intentions, as observed in both FND14, 15 and high hypnotic 
suggestibility.12, 13 
Although the two forms of suggestibility moderately covary,35 FND patients were more responsive to 
symptom-specific (SMD=1.39 [0.92, 1.86]) than to standardized suggestions (SMD=0.48 [0.15, 0.81]), 
implying selectively greater suggestibility for functional symptoms. Indeed, the sole non-significant 
provocation study36 administered suggestions for generic symptoms that did not necessarily mirror patients’ 
symptom profiles. Previous research similarly found that highly dissociative individuals and dissociative and 
acute stress disorder patients are more responsive to suggestions for dissociative experiences (e.g., 
amnesia).21 Symptom suggestibility in FND may thus partly reflect a kindling process whereby symptoms 
become more responsive to verbal suggestion over time.11, 37 
Atypical suggestibility in FND patients complements research showing greater suggestibility in germane 
conditions, such as dissociative and stress disorders10, 21 and somatoform disorders.38 The overlapping 
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symptom profiles of these conditions implies an association between suggestibility and dissociative 
psychopathology, the specificity of which is corroborated by research indicating that suggestibility does not 
seem to be a characteristic of general psychopathology.39, 40 Variability in detachment and 
compartmentalization symptoms41 and exposure to stressful life events may account for heterogeneity in the 
suggestibility profiles of FND patients, with heightened responsiveness to suggestions being specific to, or 
more pronounced among, patients with marked dissociative symptomatology.34, 42 Further research is 
required to assess whether this heterogeneity is attributable to the presence of a highly suggestible subtype 
among FND patients, who may be particularly likely to benefit from suggestion-based interventions. An 
additional outstanding question is whether atypical suggestibility is a feature shared across different FND 
symptom subtypes. The available evidence suggests this is the case: NES patients were not reliably more 
suggestible than other FND patients and independent research has documented or implied elevated 
responsiveness to suggestion in psychogenic parkinsonism,43  functional movement disorders,44-47 and 
functional vision loss.48 Moderation analyses indicated that the administration of a hypnotic induction was 
associated with greater standardized suggestibility among FND patients. This is consistent with the proposal 
that individuals with compartmentalization symptoms benefit more from a hypnotic induction21 although the 
mechanistic basis of this effect remains unclear.24  
These effects attest to the efficacy of suggestion in the diagnosis of FND.18 Suggestive symptom 
induction displayed high specificity (94%) although sensitivity is poor (49%), indicating that this technique 
is insufficient as a standalone diagnostic procedure. The inclusion of sham methods or a hypnotic induction 
were not associated with greater discrimination of FND patients and controls relative to verbal suggestion 
alone but warrant further attention. Suggestive symptom induction is likely to be especially valuable in 
suggestible populations such as adolescent and elderly samples24 or patients with comorbid dissociative or 
stress disorder diagnoses.10, 21 It may also inform diagnosis of comorbid non-epileptic seizures in epilepsy 
patients49 and medication prescription50 and prognosis51 in FND patients. Insofar as suggestibility is a 
positive predictor of outcome with suggestion-based treatments,52 these results also support greater 
incorporation of suggestion techniques in treatment protocols, which show promising results in randomized-
controlled trials.20 However, they also highlight the need to control for suggestion, or consider its role, in 
diagnostic and treatment procedures, particularly those that evoke strong response expectancies.46  
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Limitations 
The principal limitations of these data concern methodological variability across studies. Methodological 
quality was significantly or descriptively related to effect sizes in both data sets albeit in opposite directions. 
Among standardized studies, older studies that did not precisely specify inclusion/exclusion criteria and/or 
diagnostic and scale administration procedures tended to exhibit larger effect sizes; in contrast, precise 
specification of diagnostic procedures was associated with larger effect sizes in symptom studies. In most 
studies, the operator administering the assessment was not blind to patient group, which may inflate effect 
sizes23, although there was no evidence for an experimenter effect in the standardized studies. The sole blind 
symptom study had a lower effect size than the remainder of the studies but was still large in magnitude 
(SMD=0.93 [0.61, 1.26]). Most studies included clinical controls (e.g., epilepsy patients), which raises issues 
regarding generalizability although effect sizes did not significantly relate to control type. Similarly, the 
majority of FND samples comprised patients presenting with non-epileptic seizures and thus further 
controlled research is required to assess responsiveness to suggestion across a range of FND symptom 
subtypes, particularly those presenting with cognitive symptoms. Symptom suggestibility estimates are also 
confounded by baseline symptom frequency, which is not incorporated into these assessments.18 This 
potentially renders patients with high symptom frequency at an increased risk of false positive responses, 
although there is evidence that this is not the case.53 The studies also varied in whether successful responses 
to symptom induction protocols were contingent upon the typicality of the response, which accounted for 
variability in effect sizes. Standardized studies were limited insofar as only one controlled for compliance. 
In addition, standardized suggestibility scales include a disproportionate number of suggestions for 
dissociative and functional symptoms (e.g., paralysis),10, 24, 34 raising the question of whether elevated 
suggestibility in FND generalizes beyond these symptoms. Collectively, these findings underscore the need 
for optimization and standardization of suggestive symptom induction protocols,18 compliance-correction,24 
and more diverse suggestion batteries. 
 
Conclusions 
This meta-analysis corroborates the long-held view that FND is characterized by elevated suggestibility. 
Increased suggestibility has direct implications for the risk factors underlying this condition, the use of 
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suggestion to aid diagnosis, the utility of suggestion-based treatments for functional symptoms, and 
heterogeneity within this population. 
 
Acknowledgements  
The authors thank Che Ofuasia, Goldsmiths, University of London, for contributing to the data coding and 
evaluation. 
 
Contributors  
All authors conceived the project. LW carried out the database searches and data coding with assistance 
from RJB, TT, and DBT. LW and DBT performed the meta-analysis with assistance from RJB and TT. LW 
and DBT drafted the initial manuscript. All authors reviewed and approved the final version of the 
manuscript. 
 
Funding  
This study was supported by Bial Foundation bursary 70/16 (DBT) and a Gyllenbergs Foundation 
fellowship [no number] (DBT). 
 
Competing interests  
No, there are no competing interests for any author 
 
Patient consent for publication  
Not required.  
 
Provenance and peer review  
Not commissioned; externally peer reviewed. 
 
 
 
 
Suggestibility in functional neurological disorder 17 
References 
1. Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional 
neurological disorders. JAMA Neurol 2018;75:1132-1141. 
2. American Psychiatric Association. Diagnostic and statistical manual of the mental disorders (5th 
Ed.). Arlington, VA: American Psychiatric Press, 2013. 
3. Brown RJ. Dissociation and functional neurologic disorders. Handb Clin Neurol 2016;139:85-94. 
4. Carson AJ, Brown R, David AS, et al. Functional (conversion) neurological symptoms: Research 
since the millennium. J Neurol Neurosurg Psychiatry 2012;83:842-850. 
5. Benbadis SR, Allen Hauser W. An estimate of the prevalence of psychogenic non-epileptic seizures. 
Seizure 2000;9:280-281. 
6. Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics? The diagnoses made in 
3781 new patients. Clin Neurol Neurosurg 2010;112:747-751. 
7. Reuber M. The etiology of psychogenic non-epileptic seizures: Toward a biopsychosocial model. 
Neurol Clin 2009;27:909-924. 
8. Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor 
symptoms: a systematic review. J Neurol Neurosurg Psychiatry 2014;85:220-226. 
9. Janet P. The major symptoms of hysteria. London, UK: Macmillian & Co., 1907. 
10. Bell V, Oakley DA, Halligan PW, Deeley Q. Dissociation in hysteria and hypnosis: Evidence from 
cognitive neuroscience. Journal of Neurology, Neurosurgery, and Psychiatry 2011;82:332-339. 
11. Brown RJ, Reuber M. Towards an integrative theory of psychogenic non-epileptic seizures (PNES). 
Clin Psychol Rev 2016;47:55-70. 
12. Lush P, Naish P, Dienes Z. Metacognition of intentions in mindfulness and hypnosis. Neuroscience 
of Consciousness 2016:1-10. 
13. Terhune DB, Hedman LRA. Metacognition of agency is reduced in high hypnotic suggestibility. 
Cognition 2017;168:176-181. 
14. Baek K, Donamayor N, Morris LS, et al. Impaired awareness of motor intention in functional 
neurological disorder: Implications for voluntary and functional movement. Psychol Med 2017;47:1624-
1636. 
Suggestibility in functional neurological disorder 18 
15. Jungilligens J, Wellmer J, Schlegel U, Kessler H, Axmacher N, Popkirov S. Impaired emotional and 
behavioural awareness and control in patients with dissociative seizures. Psychol Med 2019:1-9. 
16. Edwards MJ, Adams RA, Brown H, Parees I, Friston KJ. A Bayesian account of 'hysteria'. Brain 
2012;135:3495-3512. 
17. Van den Bergh O, Witthoft M, Petersen S, Brown RJ. Symptoms and the body: Taking the 
inferential leap. Neurosci Biobehav Rev 2017;74:185-203. 
18. Popkirov S, Gronheit W, Wellmer J. A systematic review of suggestive seizure induction for the 
diagnosis of psychogenic nonepileptic seizures. Seizure 2015;31:124-132. 
19. LaFaver K, Lang AE, Stone J, et al. Opinions and clinical practices related to diagnosing and 
managing functional (psychogenic) movement disorders: changes in the last decade. Eur J Neurol 2020. 
20. Deeley Q. Hypnosis as therapy for functional neurologic disorders. Handb Clin Neurol 
2016;139:585-595. 
21. Terhune DB, Cardeña E. Dissociative subtypes in posttraumatic stress disorders and hypnosis: 
Neurocognitive parallels and clinical implications. Current Directions in Psychological Science 
2015;24:452-457. 
22. Brown RJ, Reuber M. Psychological and psychiatric aspects of psychogenic non-epileptic seizures 
(PNES): A systematic review. Clin Psychol Rev 2016;45:157-182. 
23. Holman L, Head ML, Lanfear R, Jennions MD. Evidence of experimental bias in the life sciences: 
Why we need blind data recording. PLoS Biol 2015;13:e1002190. 
24. Terhune DB, Cleeremans A, Raz A, Lynn SJ. Hypnosis and top-down regulation of consciousness. 
Neurosci Biobehav Rev 2017;81:59-74. 
25. Gudjonsson GH. Interrogative suggestibility and compliance. In: Ridley AM, Gabbert F, La Rooy 
DJ, eds. Suggestibility in legal contexts: Psychological research and forensic implications. Chichester, UK: 
Wiley-Blackwell, 2013: 45-61. 
26. Thompson T, Terhune DB, Oram C, et al. The effectiveness of hypnosis for pain relief: A 
systematic review and meta-analysis of 85 controlled experimental trials. Neurosci Biobehav Rev 
2019;99:298-310. 
27. Hasselblad V, Hedges LV. Meta-analysis of screening and diagnostic tests. Psychol Bull 
1995;117:167-178. 
Suggestibility in functional neurological disorder 19 
28. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, 
graphical test. BMJ 1997;315:629-634. 
29. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for 
publication bias in meta-analysis. Biometrics 2000;56:455-463. 
30. Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth 
Methods 2010;1:112-125. 
31. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. West Sussex: 
Wiley, 2008. 
32. Yard SS, DuHamel KN, Galynker, II. Hypnotizability as a potential risk factor for posttraumatic 
stress: a review of quantitative studies. The International journal of clinical and experimental hypnosis 
2008;56:334-356. 
33. Martin JR, Pacherie E. Alterations of agency in hypnosis: A new predictive coding model. Psychol 
Rev 2019;126:133-152. 
34. Roelofs K, Hoogduin KA, Keijsers GP, Naring GW, Moene FC, Sandijck P. Hypnotic susceptibility 
in patients with conversion disorder. J Abnorm Psychol 2002;111:390-395. 
35. Khan AY, Baade L, Ablah E, McNerney V, Golewale MH, Liow K. Can hypnosis differentiate 
epileptic from nonepileptic events in the video/EEG monitoring unit? Data from a pilot study. Epilepsy 
Behav 2009;15:314-317. 
36. Chabrol H, Peresson G, Clanet M. Lack of specificity of the traditional criteria for conversion 
disorders. Eur Psychiatry 1995;10:317-319. 
37. Constant EL, Adam S, Gillain B, Lambert M, Masquelier E, Seron X. Cognitive deficits in patients 
with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls. Clin 
Neurol Neurosurg 2011;113:295-302. 
38. Wickramasekera IE. Somatization: Concepts, data, and predictions from the high risk model of 
threat perception. J Nerv Ment Dis 1995;183:15-23. 
39. Frischholz EJ, Lipman LS, Braun BG, Sachs RG. Psychopathology, hypnotizability, and 
dissociation. Am J Psychiatry 1992;149:1521-1525. 
40. Pettinati HM, Kogan LG, Evans FJ, Wade JH, Horne RL, Staats JM. Hypnotizability of psychiatric 
inpatients according to two different scales. Am J Psychiatry 1990;147:69-75. 
Suggestibility in functional neurological disorder 20 
41. Holmes EA, Brown RJ, Mansell W, et al. Are there two qualitatively distinct forms of dissociation? 
A review and some clinical implications. Clin Psychol Rev 2005;25:1-23. 
42. Kuyk J, Jacobs LD, Spinhoven P, van Dyck R. Use of a dissociation questionnaire and a 
hypnotizability scale in a population with pseudo- and epileptic seizures. Epilepsia 1995;36:S173. 
43. Jankovic J. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry 
2011;82:1300-1303. 
44. Baizabal-Carvallo JF, Jankovic J. Examiner manoeuvres 'sensory tricks' in functional (psychogenic) 
movement disorders. J Neurol Neurosurg Psychiatry 2017;88:453-455. 
45. Monday K, Jankovic J. Psychogenic myoclonus. Neurology 1993;43:349-352. 
46. Edwards MJ, Bhatia KP, Cordivari C. Immediate response to botulinum toxin injections in patients 
with fixed dystonia. Mov Disord 2011;26:917-918. 
47. Demartini B, Ricciardi L, Parees I, Ganos C, Bhatia KP, Edwards MJ. A positive diagnosis of 
functional (psychogenic) tics. Eur J Neurol 2015;22:527-e536. 
48. Liu GT, Volpe NJ, Galetta SL. Functional (nonorganic) visual loss. In: Liu GT, Volpe NJ, Galetta 
SL, eds. Liu, Volpe, and Galetta’s Neuro-Ophthalmology: Diagnosis and Management (3rd Ed): Elsevier, 
2019: 379-393. 
49. Kutlubaev MA, Xu Y, Hackett ML, Stone J. Dual diagnosis of epilepsy and psychogenic 
nonepileptic seizures: Systematic review and meta-analysis of frequency, correlates, and outcomes. Epilepsy 
Behav 2018;89:70-78. 
50. Gogia B, Rai PK, Matthys SA, et al. Use of noninvasive induction techniques in the diagnosis of 
PNES. Epilepsy Behav 2019;99:106491. 
51. Gambini O, Demartini B, Chiesa V, Turner K, Barbieri V, Canevini MP. Long-term outcome of 
psychogenic nonepileptic seizures: The role of induction by suggestion. Epilepsy Behav 2014;41:140-143. 
52. Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomized controlled clinical trial of a 
hypnosis-based treatment for patients with conversion disorder, motor type. The International journal of 
clinical and experimental hypnosis 2003;51:29-50. 
53. Popkirov S, Jungilligens J, Gronheit W, Wellmer J. Diagnosing psychogenic nonepileptic seizures: 
Video-EEG monitoring, suggestive seizure induction and diagnostic certainty. Epilepsy Behav 2017;73:54-
58. 
Suggestibility in functional neurological disorder 21 
Online supplemental content 1 
 
 
Suggestibility in functional neurological disorder: A meta-analysis 
Lillian Wieder1, Richard J. Brown2,3, Che Ofuasia1, Trevor Thompson4, & Devin B. Terhune1 
 
1 Department of Psychology, Goldsmiths, University of London, London, UK 
2 School of Health Sciences, University of Manchester, Manchester, UK 
3 Complex Trauma and Resilience Research Unit, Greater Manchester Mental Health NHS Foundation 
Trust, Manchester Academic Health Sciences Centre, Manchester, UK  
4 School of Human Sciences, University of Greenwich, London, UK 
 
 
Correspondence address: 
Devin B. Terhune 
Department of Psychology 
Goldsmiths, University of London 
8 Lewisham Way 
New Cross, London, UK SE14 6NW 
d.terhune@gold.ac.uk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Suggestibility in functional neurological disorder 22 
Meta-analysis search terms 
 
The following search terms were used in the four databases (see main text):  
(hypno* OR suggestion OR suggestibility OR induc* OR placebo OR provocation) AND (psychogenic OR 
hysteri* OR somatis* OR somatiz* OR pseudo-neuro* OR "pseudo neuro*" OR pseudosens* OR 
"pseudoparalysis" OR "pseudo paralysis" OR pseudoseizure OR pseudo-seizure OR "pseudo-tumor" OR 
"functional neurological" OR "conversion disorder" OR non-epileptic OR nonepileptic OR PNES OR 
briquet* OR dissociative OR “medically unexplained”) 
 
 
Methodological quality 
 
Endorsement of criteria (1= criteria met, 0= criteria not met) 
1: Was there a clear specification of study objectives?;  
2: Was it clearly described where participants were drawn from (e.g. University etc.)?;  
3: Was it clearly described how participants were recruited (e.g. advertisement, course credits, volunteers, 
etc.)?;  
4: Was there a clear description of the inclusion and exclusion criteria?;  
5: Was the experimenter blind to group?; 
6: Were the diagnosis procedures and criteria clearly described?; 
7: Was a rigorous suggestibility scale used?; [Standardized only] 
8: Was the procedure and scale administration described in adequate detail?; [Standardized only] 
9: Was a measure included to correct for compliance?; [Standardized only] 
10: Was the symptom induction protocol clearly described?; [Symptom only] 
11: Comparability of patients and controls;  
12: Were relevant participant characteristics adequately described (age, sex etc.)?;  
13: Were complete outcome data (i.e., Ms and SDs) available (e.g. reported in article or given via response 
to data request)?  
 
 
Included studies 
 
Arain, A. M., Arbogast, P. G., & Abou-Khalil, B. W. (2009). Utility of daily supervised hyperventilation 
during long-term video-EEG monitoring. Journal of Clinical Neurophysiology: Official Publication of 
the American Electroencephalographic Society, 26(1), 17–20. 
https://doi.org/10.1097/WNP.0b013e3181969032 
Barry, J. J., Atzman, O., & Morrell, M. J. (2000). Discriminating between epileptic and nonepileptic events: 
The utility of hypnotic seizure induction. Epilepsia, 41(1), 81–84. https://doi.org/10.1111/j.1528-
1157.2000.tb01509.x 
Bliss, E. L. (1984). Hysteria and hypnosis. Journal of Nervous and Mental Disease, 172(4), 203–206. 
https://doi.org/10.1097/00005053-198404000-00003 
Brown, R. J., Schrag, A., Krishnamoorthy, E., & Trimble, M. R. (2008). Are patients with somatization 
disorder highly suggestible? Acta Psychiatrica Scandinavica, 117(3), 232–235. 
https://doi.org/10.1111/j.1600-0447.2007.01127.x 
Chabrol, H., Peresson, G., & Clanet, M. (1995). Lack of specificity of the traditional criteria for conversion 
disorders. European Psychiatry: The Journal of the Association of European Psychiatrists, 10(6), 317–
319. https://doi.org/10.1016/0924-9338(96)80314-2 
Chen-Block, S., Abou-Khalil, B. W., Arain, A., Haas, K. F., Lagrange, A. H., Gallagher, M. J., Azar, N. J., 
Singh, P., & Sonmezturk, H. H. (2016). Video-EEG results and clinical characteristics in patients with 
psychogenic nonepileptic spells: The effect of a coexistent epilepsy. Epilepsy & Behavior: E&B, 62, 62–
65. https://doi.org/10.1016/j.yebeh.2016.06.018 
Goldstein, L. H., Drew, C., Mellers, J., Mitchell-O’Malley, S., & Oakley, D. A. (2000). Dissociation, 
hypnotizability, coping styles and health locus of control: Characteristics of pseudoseizure patients. 
Seizure, 9(5), 314–322. https://doi.org/10.1053/seiz.2000.0421 
Goyal, G., Kalita, J., & Misra, U. K. (2014). Utility of different seizure induction protocols in psychogenic 
nonepileptic seizures. Epilepsy Research, 108(6), 1120–1127. 
https://doi.org/10.1016/j.eplepsyres.2014.02.015 
Suggestibility in functional neurological disorder 23 
Kandler, R., Lawrence, S., Pang, C., Lai, M., & Whitehead, K. (2018). Optimising the use of EEG in non-
epileptic attack disorder: Results of a UK national service evaluation. Seizure, 55, 57–65. 
https://doi.org/10.1016/j.seizure.2018.01.005 
Kenney, C., Diamond, A., Mejia, N., Davidson, A., Hunter, C., & Jankovic, J. (2007). Distinguishing 
psychogenic and essential tremor. Journal of the Neurological Sciences, 263(1–2), 94–99. 
https://doi.org/10.1016/j.jns.2007.06.008 
Khan, A. Y., Baade, L., Ablah, E., McNerney, V., Golewale, M. H., & Liow, K. (2009). Can hypnosis 
differentiate epileptic from nonepileptic events in the video/EEG monitoring unit? Data from a pilot 
study. Epilepsy & Behavior: E&B, 15(3), 314–317. https://doi.org/10.1016/j.yebeh.2009.04.004 
Kuyk, J., Spinhoven, P., & van Dyck, R. (1999). Hypnotic recall: A positive criterion in the differential 
diagnosis between epileptic and pseudoepileptic seizures. Epilepsia, 40(4), 485–491. 
https://doi.org/10.1111/j.1528-1157.1999.tb00745.x 
Kuyk, Jarl, Jacobs, L. D., Aldenkamp, A. P., Meinardi, H., Spinhoven, P., & Van Dycki, R. (1995). Pseudo-
epileptic seizures: Hypnosis as a diagnostic tool. Seizure, 4(2), 123–128. https://doi.org/10.1016/S1059-
1311(95)80091-3 
Lancman, M. E., Asconapé, J. J., Craven, W. J., Howard, G., & Penry, J. K. (1994). Predictive value of 
induction of psychogenic seizures by suggestion. Annals of Neurology, 35(3), 359–361. 
https://doi.org/10.1002/ana.410350319 
Litwin, R., & Cardeña, E. (2000). Demographic and seizure variables, but not hypnotizability or 
dissociation, differentiated psychogenic from organic seizures. Journal of Trauma & Dissociation, 1(4), 
99–122. https://doi.org/10.1300/J229v01n04_06 
Martínez-Taboas, A. (2002). The role of hypnosis in the detection of psychogenic seizures. The American 
Journal of Clinical Hypnosis, 45(1), 11–20. https://doi.org/10.1080/00029157.2002.10403493 
Moene, F. C., Spinhoven, P., Hoogduin, K., Sandyck, P., & Roelofs, K. (2001). Hypnotizability, 
dissociation and trauma in patients with a conversion disorder: An exploratory study. Clinical 
Psychology & Psychotherapy, 8(6), 400–410. https://doi.org/10.1002/cpp.293 
Roelofs, K., Hoogduin, K. A. L., Keijsers, G. P. J., Näring, G. W. B., Moene, F. C., & Sandijck, P. (2002). 
Hypnotic susceptibility in patients with conversion disorder. Journal of Abnormal Psychology, 111(2), 
390–395. https://doi.org/10.1037/0021-843X.111.2.390 
Spinhoven, P., Van Dyck, R., Hoogduin, K., & Schaap, C. (1991). Differences in hypnotisability of Dutch 
psychiatric outpatients according to two different scales. Australian Journal of Clinical & Experimental 
Hypnosis, 19(2), 107–116. 
Walczak, T. S., Williams, D. T., & Berten, W. (1994). Utility and reliability of placebo infusion in the 
evaluation of patients with seizures. Neurology, 44(3 Pt 1), 394–399. 
https://doi.org/10.1212/wnl.44.3_part_1.394 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Suggestibility in functional neurological disorder 24 
Supplementary Table 1. Endorsement of methodological criteria for standardized suggestibility studies (1= 
criteria met, 0= criteria not met) 
Source Question  Total 
1 2 3 4 5 6 7 8 9 11 12 13 
Khan et al., 2009 1 1 1 1 0 1 1 0 0 0 0 1 7 
Brown et al., 2008 1 1 1 1 0 1 1 1 1 0 1 1 10 
Roelofs et al., 2002 1 1 1 1 1 1 1 1 0 1 1 1 11 
Litwin and Cardeña, 2001 1 1 1 1 1 1 1 1 0 0 1 1 10 
Moene et al., 2001 / 
Spinhoven et al. 1991* 
1 1 1 1 0 1 1 1 0 0 0 1 8 
Barry et al., 2000 1 1 1 1 0 1 1 0 0 0 0 1 7 
Goldstein et al., 2000 1 1 1 1 0 1 1 1 0 0 1 1 9 
Kuyk et al., 1999 1 1 1 1 1 0 1 1 0 0 1 1 9 
Kuyk et al., 1995 1 1 1 1 1 1 1 1 0 0 1 1 10 
Bliss, 1984a 0 1 1 0 0 0 1 0 0 0 0 1 4 
Bliss, 1984b 1 1 1 0 0 0 1 0 0 0 0 1 5 
* = Control data were drawn from Spinhoven et al. (1991). 
 
 
 
 
Supplementary Table 2. Endorsement of methodological criteria for symptom suggestibility studies (1= 
criteria met, 0= criteria not met) 
Source  Question Total 
1 2 3 4 5 6 10 11 12 13 
Kandler et al., 2018 1 1 1 1 0 0 0 0 0 1 5 
Chen-Block et al., 
2016 
1 1 1 1 0 1 0 0 0 1 6 
Goyal et al., 2014 1 1 1 1 0 1 1 0 1 1 8 
Arain et al., 2009 1 1 1 1 0 0 1 0 0 1 6 
Khan et al., 2009 1 1 1 1 0 1 1 0 0 1 7 
Kenney et al., 2007 1 1 1 1 1 1 1 0 0 1 8 
Martinez-Taboas, 2002 1 1 1 0 0 1 1 1 1 1 8 
Barry et al., 2000 1 1 1 1 0 1 1 0 0 1 7 
Chabrol et al, 1995 1 1 1 1 0 0 0 0 0 1 5 
Lancman et al., 1994 1 0 0 1 0 1 1 1 1 1 7 
Walczak et al., 1994 1 1 1 0 0 1 1 0 1 1 7 
 
 
 
 
 
 
 
 
 
